Overview

Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Gastric Ulcer Participants With or Without Helicobacter Pylori Infection

Status:
Completed

Trial end date:
2020-05-26

Target enrollment:

Participant gender:

Summary

The purpose of this study is to demonstrate the non-inferior efficacy of TAK-438 versus lansoprazole in the treatment of participants with gastric ulcer.

Phase:

Phase 3

Details

Lead Sponsor:

Takeda

Treatments:

Bismuth
Dexlansoprazole
Lansoprazole
Potassium Citrate